Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MTR106: Phase II data

In a double-blind, placebo-controlled Phase II trial in 40

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE